SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:uu-15354"
 

Search: onr:"swepub:oai:DiVA.org:uu-15354" > Gene expression sig...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
  • Dyrskjøt, Lars (author)

Gene expression signatures predict outcome in non-muscle-invasive bladder carcinoma : a multicenter validation study

  • Article/chapterEnglish2007

Publisher, publication year, extent ...

  • 2007
  • printrdacarrier

Numbers

  • LIBRIS-ID:oai:DiVA.org:uu-15354
  • https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-15354URI
  • https://doi.org/10.1158/1078-0432.CCR-06-2940DOI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • Purpose: Clinically useful molecular markers predicting the clinical course of patients diagnosed with non–muscle-invasive bladder cancer are needed to improve treatment outcome. Here, we validated four previously reported gene expression signatures for molecular diagnosis of disease stage and carcinoma in situ (CIS) and for predicting disease recurrence and progression. Experimental Design: We analyzed tumors from 404 patients diagnosed with bladder cancer in hospitals in Denmark, Sweden, England, Spain, and France using custom microarrays. Molecular classifications were compared with pathologic diagnosis and clinical outcome. Results: Classification of disease stage using a 52-gene classifier was found to be highly significantly correlated with pathologic stage (P < 0.001). Furthermore, the classifier added information regarding disease progression of Ta or T1 tumors (P < 0.001). The molecular 88-gene progression classifier was highly significantly correlated with progression-free survival (P < 0.001) and cancer-specific survival (P = 0.001). Multivariate Cox regression analysis showed the progression classifier to be an independently significant variable associated with disease progression after adjustment for age, sex, stage, grade, and treatment (hazard ratio, 2.3; P = 0.007). The diagnosis of CIS using a 68-gene classifier showed a highly significant correlation with histopathologic CIS diagnosis (odds ratio, 5.8; P < 0.001) in multivariate logistic regression analysis. Conclusion: This multicenter validation study confirms in an independent series the clinical utility of molecular classifiers to predict the outcome of patients initially diagnosed with non–muscle-invasive bladder cancer. This information may be useful to better guide patient treatment.

Subject headings and genre

  • MEDICINE
  • MEDICIN

Added entries (persons, corporate bodies, meetings, titles ...)

  • Zieger, Karsten (author)
  • Real, Francisco X. (author)
  • Malats, Núria (author)
  • Carrato, Alfredo (author)
  • Hurst, Carolyn (author)
  • Kotwal, Sanjeev (author)
  • Knowles, Margaret (author)
  • Malmström, Per-UnoUppsala universitet,Institutionen för kirurgiska vetenskaper,Urologi(Swepub:uu)perunoms (author)
  • de la Torre, ManuelUppsala universitet,Institutionen för genetik och patologi(Swepub:uu)manutorr (author)
  • Wester, KennethUppsala universitet,Institutionen för genetik och patologi(Swepub:uu)kennwest (author)
  • Allory, Yves (author)
  • Vordos, Dimitri (author)
  • Caillault, Aurélie (author)
  • Radvanyi, François (author)
  • Hein, Anne-Mette K. (author)
  • Jensen, Jens L (author)
  • Jensen, Klaus M. E. (author)
  • Marcussen, Niels (author)
  • Orntoft, Torben F. (author)
  • Uppsala universitetInstitutionen för kirurgiska vetenskaper (creator_code:org_t)

Related titles

  • In:Clinical Cancer Research13:12, s. 3545-35511078-04321557-3265

Internet link

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view